Ling Hao

462 total citations
23 papers, 274 citations indexed

About

Ling Hao is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Ling Hao has authored 23 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Ling Hao's work include Tuberculosis Research and Epidemiology (5 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Pneumonia and Respiratory Infections (3 papers). Ling Hao is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Pneumonia and Respiratory Infections (3 papers). Ling Hao collaborates with scholars based in China and Sweden. Ling Hao's co-authors include Qunyi Li, Yongli Du, Meng Xiong, Xinran Li, Qiuping Zhang, Xionglin Fan, Xueyan Xi, R. Xiao, Boyu Du and Jingkang Shen and has published in prestigious journals such as Frontiers in Immunology, European Journal of Medicinal Chemistry and Theranostics.

In The Last Decade

Ling Hao

20 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Hao China 11 166 77 69 43 41 23 274
Rocío Lavado-Valenzuela Spain 8 190 1.1× 66 0.9× 65 0.9× 85 2.0× 22 0.5× 16 333
Lam Nguyen United States 9 106 0.6× 68 0.9× 38 0.6× 40 0.9× 30 0.7× 15 270
Nina Frey Switzerland 7 207 1.2× 63 0.8× 51 0.7× 107 2.5× 21 0.5× 19 373
Pradeep Kumar Kopparapu Sweden 11 207 1.2× 55 0.7× 59 0.9× 59 1.4× 99 2.4× 19 369
Yongjia Tong China 9 193 1.2× 36 0.5× 83 1.2× 53 1.2× 14 0.3× 15 329
Kentaro Nobutani Japan 12 198 1.2× 74 1.0× 61 0.9× 75 1.7× 74 1.8× 17 368
Pavithra Rajagopalan United States 10 143 0.9× 33 0.4× 83 1.2× 63 1.5× 26 0.6× 21 301
Xi Tan Canada 7 162 1.0× 33 0.4× 143 2.1× 49 1.1× 46 1.1× 8 331
Kefan Bi China 11 239 1.4× 63 0.8× 119 1.7× 45 1.0× 32 0.8× 24 389
Jianwen Chen China 11 174 1.0× 69 0.9× 94 1.4× 95 2.2× 18 0.4× 21 360

Countries citing papers authored by Ling Hao

Since Specialization
Citations

This map shows the geographic impact of Ling Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Hao more than expected).

Fields of papers citing papers by Ling Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Hao. The network helps show where Ling Hao may publish in the future.

Co-authorship network of co-authors of Ling Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Hao. A scholar is included among the top collaborators of Ling Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Hao. Ling Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hao, Ling, et al.. (2025). CD39 dynamics in tuberculosis: a potential biomarker of immune dysregulation and T cell exhaustion. Frontiers in Immunology. 16. 1601637–1601637.
3.
4.
5.
6.
7.
Hao, Ling, Yaqi Wu, Yandi Zhang, et al.. (2020). Differential Immunogenicity and Protective Efficacy Elicited by MTO‐ and DMT‐Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection. Journal of Immunology Research. 2020(1). 2083793–2083793. 4 indexed citations
8.
Hao, Ling, Yaqi Wu, Yandi Zhang, et al.. (2020). Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine. Frontiers in Immunology. 11. 575504–575504. 10 indexed citations
9.
Hao, Ling, Chunwei Shi, Xiaosong Lin, et al.. (2020). Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery. Theranostics. 10(22). 10046–10056. 2 indexed citations
10.
11.
Hao, Ling, R. Xiao, Xinran Li, et al.. (2017). Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer. Oncology Letters. 13(4). 2670–2678. 10 indexed citations
12.
Hao, Ling, Boyu Du, & Xueyan Xi. (2017). TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis. Oncology Letters. 14(2). 2153–2164. 20 indexed citations
13.
Du, Yongli, Liudi Zhang, Ling Hao, et al.. (2017). The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer. European Journal of Medicinal Chemistry. 136. 457–467. 24 indexed citations
14.
Yang, Ning, Haifei Chen, Yongli Du, et al.. (2017). A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α. Biomedicine & Pharmacotherapy. 93. 913–922. 7 indexed citations
15.
Du, Yongli, Yanhui Zhang, Ling Hao, Qunyi Li, & Jingkang Shen. (2017). Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site. European Journal of Medicinal Chemistry. 144. 692–700. 16 indexed citations
16.
Huang, Xiaoxing, Jie Xiong, Xinzhou Deng, et al.. (2017). NHE1 has a notable role in metastasis and drug resistance of T-cell acute lymphoblastic leukemia. Oncology Letters. 14(4). 4256–4262. 12 indexed citations
17.
Huang, Xiaoxing, Meng Xiong, Chaohua Deng, et al.. (2016). Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties. International Journal of Oncology. 49(1). 343–351. 7 indexed citations
18.
Tu, Zhenbo, Du He, Xinzhou Deng, et al.. (2016). An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer. Oncology Reports. 36(1). 215–222. 24 indexed citations
19.
Du, Yongli, Ling Hao, Meng Zhang, Jingkang Shen, & Qunyi Li. (2015). Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design. Bioorganic & Medicinal Chemistry. 23(15). 4891–4898. 18 indexed citations
20.
Wang, Tiejun, et al.. (2011). Knockdown of MED19 by Lentivirus-Mediated shRNA in Human Osteosarcoma Cells Inhibits Cell Proliferation by Inducing Cell Cycle Arrest in the G0/G1 Phase. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(5). 193–201. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocío Lavado-Valenzuela Breakdown of academic impact, for papers by Lam Nguyen Breakdown of academic impact, for papers by Nina Frey Breakdown of academic impact, for papers by Pradeep Kumar Kopparapu Breakdown of academic impact, for papers by Yongjia Tong Breakdown of academic impact, for papers by Kentaro Nobutani Breakdown of academic impact, for papers by Pavithra Rajagopalan Breakdown of academic impact, for papers by Xi Tan Breakdown of academic impact, for papers by Kefan Bi Breakdown of academic impact, for papers by Jianwen Chen
Rankless by CCL
2026